Fralin Biomedical Research Institute at VTC
Roanoke, Virginia, 24016, United States
NCT Number: NCT06628180
This research project is examining the effects of noninvasive brain stimulation on chronic pain. We believe this study will help us to better understand possible treatments for chronic pain patients. Subjects will undergo functional magnetic resonance imaging (fMRI) and a computed tomography (CT) scan, which is a way to take pictures of the brain and skull. Subjects will receive noninvasive brain stimulation using low-intensity focused ultrasound (LIFU) sound waves, to temporarily change brain activity. Subjects will undergo pain testing using a small device that will increase the temperature of their skin and will rate this pain. Brain signals (EEG), heart rate and rhythm, blood pressure, respiration rate, and skin moisture will be monitored. Subjects will complete behavioral questionnaires. Each study session is expected to take 1.5-3 hours. Total participation takes 10 weeks.
Interested in participating?
Request Info18 year–65 year
All sexes
Interventional
Not applicable
Roanoke, Virginia, 24016, United States
This is a 2-arm, sham-controlled, cross-over design. This study is collected over 5-7 study visits.
Initial Imaging (1): MRI and CT scans, Questionnaires, and QST Testing.
Intervention (2): Sham or verum LIFU application every 10 minutes, totaling in 8 applications. Between LIFU or Sham application quantitative sensory testing (QST) will be performed. Physiological data collection such as EEG, EDA, BP, ECG, and Respiration will be collected throughout the study visit.
Follow-Up Imaging (2-4): Following intervention sessions participants will receive a resting-state MRI. This can occur throughout the 4-weeks following an intervention visit. Participants will be scanned at least once after each intervention session.
Follow-Up Virtual Questionnaires: Following intervention sessions participants will receive a link (or a phone call if preferred) to periodically rate their pain and report on various lifestyle impacts of their chronic pain. Participants will complete these questionnaires at least twice per week in the 2 weeks following an intervention visit. These questionnaires will take less than 30 minutes.
After completing the intervention and minimum 4-week washout period, the participant will return for a second intervention visit and 3 week follow-up period.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Application of low-intensity focused ultrasound for neuromodulation
Sham application of LIFU - will appear the same to participants.
Time frame: during 2 study visits - up to 8 times per visit.
Reduced perceived sensation (pain) score in response to painful stimulus. Pain scale of 0-10, 0 being no pain and 10 being worst pain imaginable.
Time frame: 4 weeks following each intervention, every 2-4 days, 30 min per day.
quality of life questionnaires over a 4 week period following intervention
Time frame: pre and post intervention, up to 5 scans (1 pre, up to 4 post)
Changes in resting state functional connectivity.
Virginia Polytechnic Institute and State University
Other
Investigation of Accelerated LIFU: Towards Therapeutic Use for Chronic Pain
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07297901
Autonomic Nervous System, Brain Diseases
Phoenix, Arizona, United States
View Trial DetailsNCT07693998
Chronic Low Back Pain (CLBP), Chronic Pain
Valencia, Spain
View Trial DetailsNCT06228755
Chronic Pain, Neurologic Manifestations
Chapel Hill, North Carolina, United States
View Trial DetailsNCT06306157
Agnosia, Autonomic Nervous System Diseases
New York, United States
View Trial Details